Half Year 2024 Ypsomed Holding AG Earnings Call TranscriptNov 15, 2023CHF270 (-1.28%)Earnings- Full Year 2023 Ypsomed Holding AG Earnings Call TranscriptMay 24, 2023CHF226 (-1.53%)Earnings
- Full Year 2022 Ypsomed Holding AG Earnings Call TranscriptMay 25, 2022CHF139.37 (-1.55%)Earnings
- Half Year 2022 Ypsomed Holding AG Earnings Call TranscriptNov 04, 2021CHF164.49 (+5.50%)Earnings
- Full Year 2021 Ypsomed Holding AG Earnings Call TranscriptMay 26, 2021CHF151.33 (+5.56%)Earnings
- Half Year 2021 Ypsomed Holding AG Earnings Call TranscriptNov 03, 2020CHF119.63 (-0.33%)Earnings
- Full Year 2020 Ypsomed Holding AG Earnings Call TranscriptMay 27, 2020CHF140.37 (+0.86%)Earnings
- Half Year 2020 Ypsomed Holding AG Earnings Call TranscriptNov 05, 2019CHF137.58 (-5.99%)Earnings
- Full Year 2019 Ypsomed Holding AG Earnings Call TranscriptMay 23, 2019CHF127.61 (-7.38%)Earnings
Full Year 2023 Ypsomed Holding AG Earnings Call Transcript
Dear shareholders and partners, at Ypsomed, we can look back on another successful year.
In Delivery Systems, we achieved a record result with our pens and autoinjectors. In pens, we are proud to be making an important contribution to access to affordable insulin with several significant collaborations in this space. In autoinjectors, the YpsoMate 2.25 for large volumes, in particular, achieved very strong sales growth. And based on our partnerships with Abbott, Dexcom and CamDiab, we are finally achieving satisfying results in our Diabetes Care business as well.
We were able to more than double commercial sales of our YpsoPump business last year. And we are excited to significantly improve life for people with diabetes with our mylife Loop AID solution that enables users to benefit from a unique and adaptive algorithm that runs on smartphones.
We exceeded the interim target of 30,000 active pump users at the end of the financial year and see a clear path towards profitability in our pump business.
So
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
